Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer.
Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer.
复制标题
DOI:
10.1158/0008-5472.can-09-3166
复制
发表时间:
2010-01-15
期刊:
影响因子:
11.2
通讯作者:
Sitaraman SV
中科院分区:
文献类型:
--
作者:
Garg P;Sarma D;Jeppsson S;Patel NR;Gewirtz AT;Merlin D;Sitaraman SV
We have demonstrated that epithelial derived MMP-9 is upregulated during inflammatory bowel disease, mediates tissue damage during colitis and regulates goblet cell differentiation through proteoltic cleavage of Notch-1 in colon. Association of MMP-9 and Notch-1 with colon cancer has been well documented. In this study, we sought to address the role and mechanism by which MMP-9 mediates the colitis-associated colon cancer (CAC). Wild type (WT) and MMP-9 knock-out (MMP-9-/-) mice were used for in vivo studies and enterocyte cell line, Caco2-BBE, were used for in vitro studies. Azoxymethane and dextran sodium sulfate were used to induce CAC. MMP-9-/- mice showed increased susceptibility to CAC as evidenced by increased tumor multiplicity, size and mortality. CAC in MMP-9-/- is associated with increased proliferation and decreased apoptosis compared to CAC in WT mice. MMP-9-/- mice exhibited p21WAF1/Cip1 expression, but increased β-catenin expression compared to WT mice in CAC. In vitro studies of MMP-9 overexpression showed increased Notch-1 activation and reciprocal decrease in β-catenin. Notch and β-catenin/Wnt signaling are well documented as crucial molecular pathways deciding the gut epithelium differentiation and carcinogenesis. Despite being a mediator of pro-inflammatory response, MMP-9 plays a protective role and acts as a tumor suppressor in CAC by modulating Notch activation resulting in the activation of p21WAF1/Cip1 leading to suppression of β-catenin.